Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Katkin Keith
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   1,258,490    

Indirect Shares

   0      
Direct Value   $4,899,671    

Indirect Value

   $0      
Total Shares   1,258,490      
Total Value   $4,899,671      


Avanir Pharmaceuticals $0 Eledon Pharmaceuticals Ord Shs $27,995 Urovant Sciences Ltd. $3,242,803 Syndax Pharmaceuticals Inc $1,413,750 Rigel Pharmaceuticals Inc $30,500 Emergent Biosolutions Inc. $184,623 Avanir Pharmaceuticals $0 Eledon Pharmaceuticals Ord Shs $27,995 Urovant Sciences Ltd. $3,242,803 Syndax Pharmaceuticals Inc $1,413,750 Rigel Pharmaceuticals Inc $30,500 Emergent Biosolutions Inc. $184,623
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avanir Pharmaceuticals AVNR President and CEO, Dir... 2014-12-17 914,249 2006-05-25 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN Director 2017-05-10 12,119 0    Premium*  
            Urovant Sciences Ltd. UROV PEO;CEO/Urovant Scienc... 2020-02-19 199,680 2019-12-09 0    Premium*  
            Syndax Pharmaceuticals Inc SNDX 2024-02-07 65,000 2021-02-03 0    Premium*  
            Rigel Pharmaceuticals Inc RIGL Director 2021-05-19 25,000 2021-05-19 0    Premium*  
            Emergent Biosolutions Inc. EBS Director 2023-05-25 42,442 2022-04-02 0    Premium*  
* Premium Members only  

Records found :    76         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVNR Avanir Pharmaceuticals Sr. V.P. of Sales & Marketing   •       –      –    2006-12-13 4 A $0.00 $0 D/D 57,600 60,100 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2007-03-21 4 A $0.00 $0 D/D 526,316 586,416 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-12-01 4 A $0.00 $0 D/D 62,500 208,352 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2011-12-15 4 A $0.00 $0 D/D 127,000 317,857 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2012-12-17 4/A A $0.00 $0 D/D 220,500 530,107 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2014-02-12 4 A $0.00 $0 D/D 354,375 800,082 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2014-07-09 4 A $0.00 $0 D/D 20,000 770,082 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2014-11-10 4 A $0.00 $0 D/D 361,174 996,769 0 -
UROV Urovant Sciences Ltd. PEO;CEO/Urovant Sciences, Inc.   •       •      –    2020-01-07 4 A $0.00 $0 D/D 199,680 199,680 0 -
SNDX Syndax Pharmaceuticals In...   –       •      –    2021-02-03 4 A $0.00 $0 D/D 16,000 16,000 0 -
RIGL Rigel Pharmaceuticals Inc Director   –       •      –    2021-05-19 4 A $0.00 $0 D/D 25,000 25,000 0 -
SNDX Syndax Pharmaceuticals In...   –       •      –    2022-02-02 4 A $0.00 $0 D/D 16,000 32,000 0 -
EBS Emergent Biosolutions Inc... Director   –       •      –    2022-04-02 4 A $0.00 $0 D/D 8,595 8,595 0 -
SNDX Syndax Pharmaceuticals In...   –       •      –    2023-02-02 4 A $0.00 $0 D/D 16,000 48,000 0 -
EBS Emergent Biosolutions Inc... Director   –       •      –    2023-05-25 4 A $0.00 $0 D/D 33,847 42,442 0 -
SNDX Syndax Pharmaceuticals In...   –       •      –    2024-02-07 4 A $0.00 $0 D/D 17,000 65,000 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-03-29 4 AS $2.60 $78,000 D/D (30,000) 387,273 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-04-08 4 AS $3.01 $30,100 D/D (10,000) 377,273 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-04-30 4 AS $3.31 $132,372 D/D (40,000) 337,273 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-05-03 4 AS $3.06 $201,376 D/D (65,906) 271,367 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-11-01 4 AS $5.70 $114,000 D/D (20,000) 145,852 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2011-11-16 4 AS $2.59 $282,300 D/D (109,013) 208,352 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2011-11-17 4 AS $2.59 $282,657 D/D (109,012) 208,352 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2011-12-02 4 AS $2.37 $41,421 D/D (17,495) 190,857 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2012-06-25 4 AS $3.50 $664,791 D/D (190,125) 137,732 0 -
  76  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us